Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Q Bio

Explore full profile

We're building technology that quantifies, digitizes, and simulates human physiology

San Carlos, United StatesFounded 2015Biotech & Life Sciences
Valuation $100–250M Last recorded · 2024
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Q Bio and the history behind them.

About Q Bio

Q.bio is a cutting-edge startup revolutionizing the healthcare industry with its focus on preventive medicine. Founded by a seasoned scientist with a background in medicine and engineering, Q.bio aims to identify early signs of disease before symptoms appear, enabling timely intervention and better health outcomes. The company operates in the preventive healthcare market, serving both individual clients and clinicians.

Q.bio offers a comprehensive health assessment called the Q Exam, which takes about an hour at a Q Center. This exam gathers detailed information from various sources, including blood, saliva, urine, vitals, and whole-body MRI scans. The data is then securely stored in a personalized BioVault and made accessible through a web-based Q Dashboard. This dashboard is optimized for telemedicine, allowing users to share their health information with doctors, trainers, nutritionists, and other healthcare professionals worldwide.

The business model of Q.bio is subscription-based. Individuals can become Q members to access regular health assessments and continuous monitoring. Clinicians can also partner with Q.bio to integrate preventive medicine into their practice, offering their patients a more data-rich approach to healthcare.

Q.bio makes money through membership fees from individuals and partnership agreements with healthcare providers. By providing a detailed and quantitative snapshot of a person's health, Q.bio empowers clients to take control of their health and make informed decisions.

In summary, Q.bio is transforming preventive healthcare by offering detailed, data-driven health assessments that help identify early signs of disease. The company serves individuals and clinicians, operates in the preventive healthcare market, and generates revenue through memberships and partnerships.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
San Carlos, United States
Employees
40
Open positions
None listed
Dealroom signal
44.0/100
Industry
Health, Enterprise Software
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, MRI, Health Diagnostics, Spinout, AI for medical imaging, Preventive Care, DT and LS, science-based
Business model
SaaS
Client focus
b2b

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jul 2024 $27M $200M Founders Fund · Andreessen Horowitz · Khosla Ventures · Telus Ventures ↗
SERIES BOther financing Mar 2020 $40M $160M Khosla Ventures · SciFi VC · Beast Ventures · Thirty Five Ventures ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Q Bio website traffic

Latest recorded traffic for Q Bio is 4.7K monthly website visits, up 2.2% over the last three months. Q Bio's team grew 11.1% over the past year.

Latest monthly visits4.7K 3-month web change+2.2% 1-year team growth+11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A4 investors entered at this stage

Series B and later2 investors entered at this stage

  • Telus Ventures
  • Kaiser Permanente

Other known investors1 additional known investor

  • Stanford Center for Genomics and Personalized Medicine
Team profiled 18 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States96.3%
🇷🇺 Russia3.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Q Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Q Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.